Addiction: Beyond dopamine reward circuitry
Dopamine (DA) is considered crucial for the rewarding effects of drugs of abuse, but its role in addiction is much less clear. This review focuses on studies that used PET to characterize the brain DA system in addicted subjects. These studies have corroborated in humans the relevance of drug-induced fast DA increases in striatum [including nucleus accumbens (NAc)] in their rewarding effects but have unexpectedly shown that in addicted subjects, drug-induced DA increases (as well as their subjective reinforcing effects) are markedly blunted compared with controls. In contrast, addicted subjects show significant DA increases in striatum in response to drug-conditioned cues that are associated with self-reports of drug craving and appear to be of a greater magnitude than the DA responses to the drug. We postulate that the discrepancy between the expectation for the drug effects (conditioned responses) and the blunted pharmacological effects maintains drug taking in an attempt to achieve the expected reward. Also, whether tested during early or protracted withdrawal, addicted subjects show lower levels of D2 receptors in striatum (including NAc), which are associated with decreases in baseline activity in frontal brain regions implicated in salience attribution (orbitofrontal cortex) and inhibitory control (anterior cingulate gyrus), whose disruption results in compulsivity and impulsivity. These results point to an imbalance between dopaminergic circuits that underlie reward and conditioning and those that underlie executive function (emotional control and decision making), which we postulate contributes to the compulsive drug use and loss of control in addiction.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Addiction Biology
27 publications, 3.53%
|
|
|
Frontiers in Psychiatry
23 publications, 3.01%
|
|
|
Psychopharmacology
15 publications, 1.96%
|
|
|
Brain Imaging and Behavior
14 publications, 1.83%
|
|
|
Neuroscience and Biobehavioral Reviews
14 publications, 1.83%
|
|
|
Drug and Alcohol Dependence
13 publications, 1.7%
|
|
|
Neuropsychopharmacology
12 publications, 1.57%
|
|
|
Biological Psychiatry
11 publications, 1.44%
|
|
|
Human Brain Mapping
11 publications, 1.44%
|
|
|
NeuroImage
10 publications, 1.31%
|
|
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry
9 publications, 1.18%
|
|
|
Translational Psychiatry
8 publications, 1.05%
|
|
|
Frontiers in Neuroscience
7 publications, 0.92%
|
|
|
PLoS ONE
7 publications, 0.92%
|
|
|
Neuropharmacology
7 publications, 0.92%
|
|
|
Alcoholism: Clinical and Experimental Research
7 publications, 0.92%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
7 publications, 0.92%
|
|
|
Scientific Reports
6 publications, 0.79%
|
|
|
Neuroscience
6 publications, 0.79%
|
|
|
Journal of Neurochemistry
6 publications, 0.79%
|
|
|
Current Topics in Behavioral Neurosciences
6 publications, 0.79%
|
|
|
American Journal of Psychiatry
5 publications, 0.65%
|
|
|
American Journal of Drug and Alcohol Abuse
5 publications, 0.65%
|
|
|
Behavioral Sciences
5 publications, 0.65%
|
|
|
Journal of Psychiatric Research
5 publications, 0.65%
|
|
|
ACS Chemical Neuroscience
5 publications, 0.65%
|
|
|
Pharmacology Biochemistry and Behavior
5 publications, 0.65%
|
|
|
Behavioural Brain Research
5 publications, 0.65%
|
|
|
Addiction
5 publications, 0.65%
|
|
|
5
10
15
20
25
30
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
215 publications, 28.14%
|
|
|
Springer Nature
140 publications, 18.32%
|
|
|
Wiley
99 publications, 12.96%
|
|
|
Frontiers Media S.A.
54 publications, 7.07%
|
|
|
MDPI
30 publications, 3.93%
|
|
|
Taylor & Francis
23 publications, 3.01%
|
|
|
Cold Spring Harbor Laboratory
22 publications, 2.88%
|
|
|
Oxford University Press
19 publications, 2.49%
|
|
|
SAGE
12 publications, 1.57%
|
|
|
Cambridge University Press
9 publications, 1.18%
|
|
|
American Chemical Society (ACS)
8 publications, 1.05%
|
|
|
Public Library of Science (PLoS)
8 publications, 1.05%
|
|
|
American Psychiatric Association Publishing
7 publications, 0.92%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
7 publications, 0.92%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
6 publications, 0.79%
|
|
|
Annual Reviews
5 publications, 0.65%
|
|
|
American Psychological Association (APA)
5 publications, 0.65%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
3 publications, 0.39%
|
|
|
American Medical Association (AMA)
3 publications, 0.39%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
3 publications, 0.39%
|
|
|
Society for Neuroscience
3 publications, 0.39%
|
|
|
Mary Ann Liebert
2 publications, 0.26%
|
|
|
MIT Press
2 publications, 0.26%
|
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 0.26%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.26%
|
|
|
CAIRN
2 publications, 0.26%
|
|
|
CMA Impact Inc.
2 publications, 0.26%
|
|
|
AIP Publishing
1 publication, 0.13%
|
|
|
American Society for Clinical Investigation
1 publication, 0.13%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.